CONCORD — The attorney general’s office announced Wednesday that New Hampshire has joined a multi-state lawsuit against 20 drug companies, alleging that they conspired to fix prices on generic prescription drugs.
The amended complaint alleges that Teva Pharmaceuticals and 19 of its competitors were involved in a broad conspiracy to artificially inflate and manipulate prices, reduce competition and unreasonably restrain trade for more than 100 different generic drugs. The drugs at issue account for billions of dollars of sales in the United States.
Specifically, New Hampshire officials allege violations under the consumer protection act and antitrust laws related to using unfair or deceptive business acts including price fixing of generic drugs, and impairing competition for these products sold to New Hampshire consumers.
The complaint also alleges the companies named were responsible for the sales, marketing, pricing and alleged schemes that lead to increased prices affecting the health insurance market, taxpayer-funded healthcare programs like Medicare and Medicaid, and individuals who must pay artificially-inflated prices for their prescriptions drugs.
The lawsuit seeks damages and injunctive relief by the court to restore competition to the generic drug market.
New Hampshire joined the amended complaint on Oct. 31, 2019.